Sgarlata, Eleonora
Chisari, Clara Grazia
D’Amico, Emanuele
Millefiorini, Enrico
Patti, Francesco http://orcid.org/0000-0002-6923-0846
Article History
First Online: 27 March 2020
Compliance with Ethical Standards
:
: This study was not fonded.
: Eleonora Sgarlata declares there is no conflict of interest. Clara G. Chisari declares there is no conflict of interest. Emanuele D’Amico declares there is no conflict of interest. Enrico Millefiorini received grants from Biogen, Merck Serono, Novartis Genzyme and Roche, consulting fees from Biogen, Merck Serono, Novartis Genzyme and Roche, travel support for congress participations from Biogen, Merck Serono, Novartis Genzyme and Roche; he also served as advisory board member for Bayer, Biogen, Merck Serono, Novartis Genzyme and Roche. Francesco Patti received grants from Almirall, Bayer, Biogen, Merck Serono, Novartis Genzyme, Teva and Roche, consulting fees from Biogen, Merck Serono, Novartis Genzyme and Roche, travel support for congress participations from Almirall, Biogen, Merck Serono, Novartis Genzyme, Teva and Roche; he also served as advisory board member for Almirall, Bayer, Biogen, Merck Serono, Novartis, Genzyme, Teva and Roche. He was also fonded by Pfizer and FISM for epidemiological studies.
: This study protocol was approved by the local Ethical Committee of the University of Catania (Catania 1).
: Each patient participating to the study signed an Informed Consent specifically designed for the study.